The jab NOT sage, especially for Lyme patients
Novo Nordisk announced this positive news via a press release on the day the case was decided
Clinical data from the SURMOUNT trials demonstrated approximately 20% body weight reduction over 68 weeks with tirzepatide versus 15% with semaglutide
But based on what we know about it and other peptides, we can deduce what an ordinary regimen might look like
Obesity Management in Adults: A Review
Several potential mechanisms may explain the cardiovascular benefit of semaglutide beyond adiposity reduction, the studys authors suggest, including effects on endothelial function and other atherosclerotic pathways, modulation of inflammation, or effects on blood pressure control, for example